Answers are grounded in this paper and cite their sources.
Endothelin-1 is a potent vasoactive peptide that exerts its action via endothelin-A (ETA) and endothelin-B (ETB) receptors. Both types of receptor belong to the rhodopsin-like (class A) G protein-coupled receptors. Since there is an increasing body of evidence that G protein-coupled receptors function as homo- and heterodimers, we sought to prove whether endothelin receptor subtypes also exist as homodimers. To this end we generated plasmids encoding fusion proteins of the endothelin-A and endothelin-B receptor with cyan (ETA.CFP, ETB.CFP) or yellow fluorescent protein (ETA.YFP, ETB.YFP), suitable for fluorescence resonance energy transfer experiments. HEK293 cells transiently co-expressing either ETA.CFP and ETA.YFP or ETB.CFP and ETB.YFP showed significant fluorescence resonance energy transfer. The calculated efficiencies of fluorescence resonance energy transfer were between 12 and 18% for both endothelin-A and endothelin-B receptor homodimers. When cells co-expressing ETA.CFP and ETA.YFP or ETB.CFP and ETB.YFP were treated with endothelin-1 for 30 minutes at 37degreesC, no change in fluorescence resonance energy transfer efficiencies was found. Similarly, the endothelin-A receptor-selective antagonist, BQ123, and the endothelin-B receptor-selective antagonist, BQ788, did not change the fluorescence resonance energy transfer efficiencies of ETA.CFP/ ETA.YFP and ETB.CFP/ETB.YFP homodimers, respectively. The data demonstrate that endothelin-A and endothelin-B receptors exist as constitutive homodimers, which are not altered in the presence of agonists or antagonists.
No takes yet. Share an insight, caveat, or question.
Gregan et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: